Category: SF1
2017
PopularThe OIE Commitment to overcoming Antimicrobial Resistance and why it is important
Dr Elisabeth Erlacher-Vinde, Head of Science and New Technologies Department at the World Organisation for Animal Health (OIE); Professor Jacques Acar, Senior Expert, World Organisation for Animal Health (OIE) and Professor...
Economics and Innovation
LatestThe Economics of reducing antibiotic use to reduce antimicrobial resistance
Dr Edward I Broughton Director of Research and Evaluation, Q&P Institute, USAID ASSIST URC, USA Human consumption of antibiotics is only beneficial to societal welfare when the correct antibiotics are used and they are given...
2017
Healthcare
PopularImproving rational antibiotic treatment of common childhood conditions in Uganda
Dr Tamar Chitashvili, Md, Senior Improvement Advisor, University Research Co., Llc, Uganda; Dr Ekaterine Cherkezishvili, Md, Mph, Research Consultant, University Research Co., Llc, Uganda; Dr Esther Karamagi, Md, Mbchb, Msc,...
Economics and Innovation
Top RatedThe role of the biomedical advanced research and development authority (BARDA) in promoting innovation in antibacterial product development
Dr Christopher Houchens, Branch Chief, Antibacterial Program and Dr Joe Larsen Deputy Director, Division of CBRN Medical Countermeasures, Biomedical Advanced Research and Development Authority, Office of Assistant Secretary for...
All
LatestInterview: Malin Grape
Interview: Malin Grape AMR Control interviews Malin Grape, the newly appointed and first Swedish Ambassador for Antimicrobial Resistance The new AMR Ambassador, Malin Grape, is currently head of the Public Health Agency of...
- All
- Diagnostics
- Rational use of antibiotics
Interview: Malin Grape
Interview: Malin Grape AMR Control interviews Malin Grape, the newly appointed and first Swedish Ambassador for Antimicrobial Resistance The new AMR Ambassador, Malin Grape, is currently head of the Public Health Agency of...
Augmented* medicine for all
Fabienne Ostermeyer, International Development Director, Visiomed Group International Imagine if...
The evolution of the global antibiotic resistance partnership
Hellen Gelband, Associate Director for Policy, Center for Disease Dynamics, Economics & Policy...
Global Health Dynamics
Cancer Control
